市場調査レポート

ヘパリン (非分画ヘパリン、低分子量ヘパリン、超低分子量ヘパリン) の欧州市場 - 2014〜2022年:業界分析、規模、シェア、成長、動向および予測

Heparin Market (Unfractionated Heparin, Low Molecular Weight Heparin & Ultra Low Molecular Weight Heparin) - Europe Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022

発行 Transparency Market Research 商品コード 335188
出版日 ページ情報 英文 68 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
ヘパリン (非分画ヘパリン、低分子量ヘパリン、超低分子量ヘパリン) の欧州市場 - 2014〜2022年:業界分析、規模、シェア、成長、動向および予測 Heparin Market (Unfractionated Heparin, Low Molecular Weight Heparin & Ultra Low Molecular Weight Heparin) - Europe Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022
出版日: 2015年06月12日 ページ情報: 英文 68 Pages
概要

当レポートでは、欧州のヘパリン市場について詳細に分析し、2012〜2022年の成長見通し、製品別、国別動向、および参入企業のプロファイルをまとめています。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • イントロダクション
  • 市場促進因子
    • 欧州における凝固および腎疾患の発症率上昇がヘパリン製品の需要を促進
    • 中国からの輸入禁止が欧州での生産を促進
    • 食肉処理業者が粗ヘパリン加工ビジネスに参入しようとしていることが欧州の需給ギャップを解消する見込み
  • 市場阻害因子
    • 合成ヘパリンおよび他の抗凝固剤などの代替製品の存在が生物学的ヘパリン製品の売上を阻害
    • 品質管理対策と環境対応の強化がヘパリン生産のコストを上げる
  • 市場の機会
    • 生物学的製品の代替品としてのバイオシミラー
    • 海洋ヘパリン製品に関する代替品研究
  • バリューチェーン分析
  • 市場の魅力度分析
  • 市場シェア分析
  • 平均価格

第4章 製品別市場

  • イントロダクション
  • 非分画ヘパリン
  • 低分子量ヘパリン
  • 超低分子量ヘパリン

第5章 国別市場

  • 概要
  • 国別市場収益
  • 英国
  • ドイツ
  • フライス
  • スペイン
  • イタリア
  • その他

第6章 提言

第7章 企業プロファイル

  • Dr. Reddy's Laboratories Ltd.
  • Fresenius Kabi AG
  • GlaxoSmithKline plc
  • Leo Pharma A/S
  • Pfizer, Inc.
  • Sanofi S.A.
  • Syntex S.A.

図表

目次

This report provides in-depth analysis of the heparin market in Europe. Stakeholders for this report include manufacturers of heparin products, crude heparin suppliers, heparin processing companies, and new players planning to enter the market.

The report provides qualitative and quantitative analysis of the heparin market in Europe. Qualitative analysis comprises market dynamics, trends, product overview, and country-level market information. Quantitative analysis includes market share held by companies in 2013, market size, and forecast for heparin product types across five major nations in Europe from 2012 to 2022. Market revenue is provided in terms of USD million from 2012 to 2022 along with the compound annual growth rate (CAGR %) from 2014 to 2022 for all the segments, considering 2013 as the base year. The executive summary of the report provides a snapshot of the heparin market in Europe with information on leading segments with respect to the market size, forecast value, market share of key players, growth rate (CAGR %) from 2014 to 2022, and growth factors.

The market overview section comprises impact factors such as drivers, restraints, and opportunities for the heparin market in Europe. This factors would aid the stakeholders in establishing a strong foothold in the European heparin market. Furthermore, the market overview section comprises market attractiveness and value chain analysis. The market attractiveness analysis section provides a graphical view comparing the growth and market dynamics in different countries to identify the most attractive market for the period from 2014 to 2022. Value chain analysis offers detailed information on value addition activities in the manufacturing process of heparin-based pharmaceutical products.

Market share analysis is also provided in the market overview section of the report for the year 2013 in terms of value (%). Furthermore, the report analyzes different heparin product types such as unfractionated heparin, low molecular weight heparin, and ultra-low molecular weight heparin. The product type section provides market analysis for different types of heparin in Europe. This includes an overview of product types, indications for use, presence of any biosimilars, market drivers, issues, and regulations amended for its production and use. Prices of products vary based on product type and formulation. Formulations with different heparin concentrations and formulation type carry different prices across the countries in the European Union. Hence, the report provides average pricing analysis (based on the current prices) to offer an overview of prices of heparin-based pharmaceutical products in the EU.

The report further provides market analysis for heparin in five major countries in the EU: the U.K., Germany, France, Italy, and Spain. Market analysis for different heparin types is provided for each of these countries from 2012 to 2022 along with the CAGR from 2014 to 2022. The market has been estimated for finished heparin formulation and has not considered its APIs. Major factors such as aging population and increasing prevalence of venous thromboembolism (VTE) that propel the market for heparin in Europe are elaborated in the country-level analysis. This section also covers certain regulations governing the manufacture and import of heparin in some countries.

Major players operating in the heparin market in Europe such as Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc, Leo Pharma A/S, Pfizer, Inc., Sanofi S.A., and Syntex S.A. are profiled in this report. The report also provides important recommendations for these players and new entrants. These recommendations would enable the existing market players to expand their market share and help new companies establish their presence in the heparin market in Europe.

The Europe Heparin Market is segmented into the following categories:

Europe Heparin Market, by Product

  • Unfractionated Heparin
  • Low Molecular Weight Heparin (LMWHs)
  • Ultra-low Molecular Weight Heparin (ULMWHs)

Europe Heparin Market, by Country

  • United Kingdom
    • Unfractionated Heparin
    • Low Molecular Weight Heparin (LMWHs)
    • Ultra-low Molecular Weight Heparin (ULMWHs)
  • Germany
    • Unfractionated Heparin
    • Low Molecular Weight Heparin (LMWHs)
    • Ultra-low Molecular Weight Heparin (ULMWHs)
  • France
    • Unfractionated Heparin
    • Low Molecular Weight Heparin (LMWHs)
    • Ultra-low Molecular Weight Heparin (ULMWHs)
  • Spain
    • Unfractionated Heparin
    • Low Molecular Weight Heparin (LMWHs)
    • Ultra-low Molecular Weight Heparin (ULMWHs)
  • Italy
    • Unfractionated Heparin
    • Low Molecular Weight Heparin (LMWHs)
    • Ultra-low Molecular Weight Heparin (ULMWHs)
  • Rest of the Europe
    • Unfractionated Heparin
    • Low Molecular Weight Heparin (LMWHs)
    • Ultra-low Molecular Weight Heparin (ULMWHs)

Table of Contents

Chapter 1 Introduction

  • 1.1 Report Description
  • 1.2 Research Methodology
    • 1.2.1 Secondary Research
    • 1.2.1 Primary Research
  • 1.3 Assumptions and Stipulations
  • 1.4 Market Segmentation

Chapter 2 Executive Summary

Chapter 3 Market Overview

  • 3.1 Introduction
  • 3.2 Market Drivers
    • 3.2.1 Rising incidence of coagulation and renal disorders in Europe to propel demand for heparin products
    • 3.2.2 Ban on imports from China to boost production in European
    • 3.2.3 Inclination of slaughterhouse owners to enter crude heparin processing business expected to overcome demand supply gap in Europe
  • 3.3 Market Restraints
    • 3.3.1 Presence of alternatives such as synthetic heparin and other anticoagulants impeding sales of biological-based heparin products
    • 3.3.2 Enhanced quality control measures and environmental factors elevating the cost of heparin production
  • 3.4 Market Opportunities
    • 3.4.1 Biosimilars as an alternative to biological based products
    • 3.4.2 Research activities on marine-based heparin products
  • 3.5 Value Chain Analysis: Europe Heparin Market
  • 3.6 Market Attractiveness Analysis: Europe Heparin Market, by Country
  • 3.7 Market Share Analysis: Europe Heparin Market, by Key Players, 2013
  • 3.8 Average Pricing

Chapter 4 Europe Heparin Market, by Product

  • 4.1 Introduction
    • 4.1.1 Europe Heparin Market Revenue, by Product, 2012 - 2022 (USD Million)
  • 4.2 Unfractionated Heparin
    • 4.2.1 Europe Unfractionated Heparin Market Revenue, 2012 - 2022 (USD Million)
  • 4.3 Low Molecular Weight Heparin
    • 4.3.1 Europe Low Molecular Weight Heparin Market Revenue, 2012 - 2022 (USD Million)
  • 4.4 Ultra-low Molecular Weight Heparin
    • 4.4.1 Europe Ultra-low Molecular Weight Heparin Market Revenue, 2012 - 2022 (USD Million)

Chapter 5 Europe Heparin Market, by Country

  • 5.1 Overview
    • 5.1.1 Europe Heparin Market Revenue, by Country, 2012 - 2022 (USD Million)
    • 5.1.2 United Kingdom
      • 5.1.2.1 United Kingdom Heparin Market Revenue, by Product, 2012 - 2022 (USD Million)
    • 5.1.3 Germany
      • 5.1.3.1 Germany Heparin Market Revenue, by Product, 2012 - 2022 (USD Million)
    • 5.1.4 France
      • 5.1.4.1 France Heparin Market Revenue, by Product, 2012 - 2022 (USD Million)
    • 5.1.5 Spain
      • 5.1.5.1 Spain Heparin Market Revenue, by Product, 2012 - 2022 (USD Million)
    • 5.1.6 Italy
      • 5.1.6.1 Italy Heparin Market Revenue, by Product, 2012 - 2022 (USD Million)
    • 5.1.7 Rest of Europe (RoE)
      • 5.1.7.1 Rest of Europe Heparin Market Revenue, by Product, 2012 - 2022 (USD Million)

Chapter 6 Recommendations

  • 6.1 Perform Quality Measures
  • 6.2 Commercializing Biosimilars at a Lower Cost to Increase its Preference Over the Branded Products

Chapter 7 Company Profiles

  • 7.1 Dr. Reddy's Laboratories Ltd.
    • 7.1.1 Company Overview
    • 7.1.2 Financial Overview
    • 7.1.3 Product Portfolio
    • 7.1.4 Business Strategies
    • 7.1.5 Recent Developments
  • 7.2 Fresenius Kabi AG
    • 7.2.1 Company Overview
    • 7.2.2 Financial Overview
    • 7.2.3 Product Portfolio
    • 7.2.4 Business Strategies
    • 7.2.5 Recent Developments
  • 7.3 GlaxoSmithKline plc
    • 7.3.1 Company Overview
    • 7.3.2 Financial Overview
    • 7.3.3 Product Portfolio
    • 7.3.4 Business Strategies
    • 7.3.5 Recent Developments
  • 7.4 Leo Pharma A/S
    • 7.4.1 Company Overview
    • 7.4.2 Financial Overview
    • 7.4.3 Product Portfolio
    • 7.4.4 Business Strategies
    • 7.4.5 Recent Developments
  • 7.5 Pfizer, Inc.
    • 7.5.1 Company Overview
    • 7.5.2 Financial Overview
    • 7.5.3 Product Portfolio
    • 7.5.4 Business Strategies
    • 7.5.5 Recent Developments
  • 7.6 Sanofi S.A.
    • 7.6.1 Company Overview
    • 7.6.2 Financial Overview
    • 7.6.3 Product Portfolio
    • 7.6.4 Business Strategies
    • 7.6.5 Recent Developments
  • 7.7 Syntex S.A.
    • 7.7.1 Company Overview
    • 7.7.2 Financial Overview
    • 7.7.3 Product Portfolio
    • 7.7.4 Business Strategies
    • 7.7.5 Recent Developments

List of Figures

  • FIG. 1 Europe Heparin Market Segmentation
  • FIG. 2 Europe Heparin Market, by Geography, 2013 (USD Million)
  • FIG. 3 Value Chain Analysis: Europe Heparin Market
  • FIG. 4 Market Attractiveness Analysis of the Europe Heparin Market, by Country
  • FIG. 5 Market Share Analysis: Europe Heparin Market, by Key Players, 2013 (Value %)
  • FIG. 6 Europe Unfractionated Heparin Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 7 Europe Low Molecular Weight Heparin Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 8 Europe Ultra-low Molecular Weight Heparin Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 9 United Kingdom Heparin Market Revenue, by Product, 2012 - 2022 (USD Million)
  • FIG. 10 Germany Heparin Market Revenue, by Product, 2012 - 2022 (USD Million)
  • FIG. 11 France Heparin Market Revenue, by Product, 2012 - 2022 (USD Million)
  • FIG. 12 Spain Heparin Market Revenue, by Product, 2012 - 2022 (USD Million)
  • FIG. 13 Italy Heparin Market Revenue, by Product, 2012 - 2022 (USD Million)
  • FIG. 14 Italy Heparin Market Revenue, by Product, 2012 - 2022 (USD Million)
  • FIG. 15 Dr. Reddy's Laboratories Ltd.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 16 Fresenius Kabi: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 17 GlaxoSmithKline plc: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 18 LEO Pharma A/S: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 19 Pfizer, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 20 Sanofi S.A. : Annual Revenue, 2011 - 2013 (USD Million)

List of Tables

  • TABLE 1 Market Snapshot: Europe Heparin Market
  • TABLE 2 Europe Heparin Market, Average Prices, 2015 and 2022 (USD)
  • TABLE 3 Europe Heparin Market Revenue, by Product, 2012 - 2022 (USD Million)
  • TABLE 4 Europe Heparin Market Revenue, by Country, 2012 - 2022 (USD Million)
Back to Top